Kraig Biocraft Labs Stock Probability of Future OTC Stock Price Finishing Over 0.0867

KBLB Stock  USD 0.08  0.00  0.00%   
Kraig Biocraft's future price is the expected price of Kraig Biocraft instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kraig Biocraft Labs performance during a given time horizon utilizing its historical volatility. Check out Kraig Biocraft Backtesting, Kraig Biocraft Valuation, Kraig Biocraft Correlation, Kraig Biocraft Hype Analysis, Kraig Biocraft Volatility, Kraig Biocraft History as well as Kraig Biocraft Performance.
  
Please specify Kraig Biocraft's target price for which you would like Kraig Biocraft odds to be computed.

Kraig Biocraft Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kraig Biocraft for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kraig Biocraft Labs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kraig Biocraft Labs generated a negative expected return over the last 90 days
Kraig Biocraft Labs has some characteristics of a very speculative penny stock
Kraig Biocraft Labs has high historical volatility and very poor performance
Kraig Biocraft Labs currently holds 95.24 K in liabilities. Kraig Biocraft Labs has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Kraig Biocraft until it has trouble settling it off, either with new capital or with free cash flow. So, Kraig Biocraft's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kraig Biocraft Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kraig to invest in growth at high rates of return. When we think about Kraig Biocraft's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (8.05 M) with profit before overhead, payroll, taxes, and interest of 0.
Kraig Biocraft Labs currently holds about 4.82 M in cash with (1.8 M) of positive cash flow from operations.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders

Kraig Biocraft Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kraig OTC Stock often depends not only on the future outlook of the current and potential Kraig Biocraft's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kraig Biocraft's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding927.4 M
Short Long Term Debt2.2 M
Shares Float767.2 M

Kraig Biocraft Technical Analysis

Kraig Biocraft's future price can be derived by breaking down and analyzing its technical indicators over time. Kraig OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kraig Biocraft Labs. In general, you should focus on analyzing Kraig OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Kraig Biocraft Predictive Forecast Models

Kraig Biocraft's time-series forecasting models is one of many Kraig Biocraft's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kraig Biocraft's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Kraig Biocraft Labs

Checking the ongoing alerts about Kraig Biocraft for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kraig Biocraft Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kraig Biocraft Labs generated a negative expected return over the last 90 days
Kraig Biocraft Labs has some characteristics of a very speculative penny stock
Kraig Biocraft Labs has high historical volatility and very poor performance
Kraig Biocraft Labs currently holds 95.24 K in liabilities. Kraig Biocraft Labs has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Kraig Biocraft until it has trouble settling it off, either with new capital or with free cash flow. So, Kraig Biocraft's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kraig Biocraft Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kraig to invest in growth at high rates of return. When we think about Kraig Biocraft's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (8.05 M) with profit before overhead, payroll, taxes, and interest of 0.
Kraig Biocraft Labs currently holds about 4.82 M in cash with (1.8 M) of positive cash flow from operations.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders

Other Information on Investing in Kraig OTC Stock

Kraig Biocraft financial ratios help investors to determine whether Kraig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kraig with respect to the benefits of owning Kraig Biocraft security.